Raymond James Financial Investing Cash Flow increased by 28.3% to -$1.34B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 102.9%, from -$659.00M to -$1.34B. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -4.2% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$720.00M | -$1.98B | -$1.56B | -$848.00M | -$2.72B | -$2.03B | -$666.00M | $347.00M | $387.00M | -$342.00M | -$176.00M | $67.00M | -$648.00M | -$211.00M | -$937.00M | -$659.00M | -$1.30B | -$1.42B | -$1.87B | -$1.34B |
| QoQ Change | — | -175.4% | +21.6% | +45.5% | -220.3% | +25.2% | +67.2% | +152.1% | +11.5% | -188.4% | +48.5% | +138.1% | <-999% | +67.4% | -344.1% | +29.7% | -97.6% | -9.3% | -31.1% | +28.3% |
| YoY Change | — | — | — | — | -277.2% | -2.5% | +57.2% | +140.9% | +114.2% | +83.2% | +73.6% | -80.7% | -267.4% | +38.3% | -432.4% | <-999% | -100.9% | -574.4% | -99.0% | -102.9% |